You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 22, December 10, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunologic Aspects of Lung Diseases and Cystic Fibrosis

Paul A. Greenberger, MD

JAMA. 1997;278(22):1924-1930.


Abstract

Immunologic lung disorders are accompanied by an array of laboratory abnormalities, some of which contribute to disease pathogenesis. Allergic bronchopulmonary aspergillosis, which complicates asthma and cystic fibrosis, causes mucous plugging of airways, eosinophilic pneumonia, and bronchiolitis obliterans. Aspergillus fumigatus, growing saprophytically in bronchial mucus, is responsible for most cases, and prednisone, not antifungal agents, is the drug of choice because it controls the immunologic responses of the lung. In cystic fibrosis, epithelial surface fluid from the lung does not kill Pseudomonas aeruginosa, in part because antibodies to P aeruginosa are plentiful but ineffective in opsonizing bacteria. Neutrophil-derived elastase cleaves immunoglobulins and digests the C3b receptor on neutrophils, which limits phagocytosis of pathogens. In helminth infections and infestations, pulmonary and peripheral blood eosinophilia can be accompanied by increases in total and antiparasite IgE concentrations and generate TH2 CD4+ T-lymphocyte responses. Understanding the immunologic abnormalities of lung disorders may lead to more effective therapies.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Pseudomonas aeruginosa PsrA responds to long-chain fatty acid signals to regulate the fadBA5 {beta}-oxidation operon
Kang et al.
Microbiology 2008;154:1584-1598.
ABSTRACT | FULL TEXT  

Pulmonary aspergillosis: a clinical update
Zmeili and Soubani
QJM 2007;100:317-334.
ABSTRACT | FULL TEXT  

The Development of Early Host Response to Pseudomonas aeruginosa Lung Infection Is Critically Dependent on Myeloid Differentiation Factor 88 in Mice
Power et al.
J. Biol. Chem. 2004;279:49315-49322.
ABSTRACT | FULL TEXT  

The Clinical Spectrum of Pulmonary Aspergillosis*
Soubani and Chandrasekar
Chest 2002;121:1988-1999.
ABSTRACT | FULL TEXT  

Sinobronchial Allergic Mycosis* : The SAM Syndrome
Venarske and deShazo
Chest 2002;121:1670-1676.
ABSTRACT | FULL TEXT  

Increased proteolytic activity and matrix metalloprotease expression in lungs during infection by porcine reproductive and respiratory syndrome virus
Girard et al.
J. Gen. Virol. 2001;82:1253-1261.
ABSTRACT | FULL TEXT  

Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Marchand et al.
Chest 2001;119:762-767.
ABSTRACT | FULL TEXT  

Proteolytic Cleavage of ICAM-1 by Human Neutrophil Elastase
Champagne et al.
J. Immunol. 1998;161:6398-6405.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.